Ligand Pharma (LGND) PT Raised to $162 at Stephens Citing Compelling Risk/Reward on Co's Imaging Agent Work
Stephens raised its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
